Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T F Kennedy

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response" [J Hepatol (2025) 101382]Douglas L Fink, David Etoori, Robert Hill, et al.
The Journal of Experimental Medicine|December 21, 2012
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletionDimitra Peppa, Upkar S Gill, Gary Reynolds, et al.
Gut|November 5, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT studyPatrick T F Kennedy, Scott Fung, Maria Buti, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-responseDouglas L Fink, David Etoori, Robert Hill, et al.
The Journal of Infectious Diseases|August 27, 2014
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?Upkar S Gill, Alexandra Zissimopoulos, Safa Al-Shamma, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
Gut|January 6, 2021
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis BValentina Svicher, Romina Salpini, Lorenzo Piermatteo, et al.
Scientific Reports|July 19, 2017
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosisHarsimran D Singh, Itziar Otano, Krista Rombouts, et al.
NPJ Vaccines|February 5, 2026
Safety, immunogenicity, and baseline immune correlates of vaccine JNJ-0535 in participants with or without CHBSimon Verheijden, Nádia Conceição-Neto, Stefan Bourgeois, et al.
Gut|April 27, 2026
The UK experience with hepatitis B immunoglobulin use following liver transplantation: wide variation in practice despite evidence supporting cost-effective HBIG-free prophylaxisAlmuthana Mohamed, Maria Guerra Veloz, Lindsay Greenland, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
JHEP Reports : Innovation in Hepatology|October 24, 2025
Corrigendum to "Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-response" [J Hepatol (2025) 101382]Douglas L Fink, David Etoori, Robert Hill, et al.
The Journal of Experimental Medicine|December 21, 2012
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletionDimitra Peppa, Upkar S Gill, Gary Reynolds, et al.
Gut|November 5, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT studyPatrick T F Kennedy, Scott Fung, Maria Buti, et al.
JHEP Reports : Innovation in Hepatology|April 25, 2025
Auto-antibodies against interferons are common in people living with chronic hepatitis B virus infection and associate with PegIFNα non-responseDouglas L Fink, David Etoori, Robert Hill, et al.
The Journal of Infectious Diseases|August 27, 2014
Assessment of bone mineral density in tenofovir-treated patients with chronic hepatitis B: can the fracture risk assessment tool identify those at greatest risk?Upkar S Gill, Alexandra Zissimopoulos, Safa Al-Shamma, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Preserved CD4 <sup>+</sup> T cell helper function and coordinated antiviral immunity in people with HBV/HIV co-infection on long-term therapyAljawharah Alrubayyi, Anucha Preechanukul, Yinru Zhang, et al.
Gut|January 6, 2021
Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis BValentina Svicher, Romina Salpini, Lorenzo Piermatteo, et al.
Scientific Reports|July 19, 2017
TRAIL regulatory receptors constrain human hepatic stellate cell apoptosisHarsimran D Singh, Itziar Otano, Krista Rombouts, et al.
NPJ Vaccines|February 5, 2026
Safety, immunogenicity, and baseline immune correlates of vaccine JNJ-0535 in participants with or without CHBSimon Verheijden, Nádia Conceição-Neto, Stefan Bourgeois, et al.
Gut|April 27, 2026
The UK experience with hepatitis B immunoglobulin use following liver transplantation: wide variation in practice despite evidence supporting cost-effective HBIG-free prophylaxisAlmuthana Mohamed, Maria Guerra Veloz, Lindsay Greenland, et al.
Pageof 8